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ess: Harri.Stark@kuh.fiSummary Nitric oxide (NO) is an important biological mediator with a variety of
cellular and tissue functions. Fractional exhaled (FENO) and nasal NO (FNNO) are
known to be altered in several respiratory tract disease and disorders. However,
there are rather few studies into the reproducibility of FENO or FNNO measurements
in healthy subjects.
The aim of this study was to examine both short- and long-term variations of FENO
and FNNO. In addition to intraday, day-to-day and week-to-week variations, the
seasonal variation was assessed.
The data revealed that FENO and FNNO levels were lower in the mornings
compared to the afternoon values. There were clinically significant correlations in
day-to-day (morning values 121.4737.5 vs. 119.8729.6, r ¼ 0:868, P ¼ 0:000),
week-to-week (morning values 121.4737.5 vs. 128.0732.1, r ¼ 0:637, P ¼ 0:000)
and seasonal (winter 133.5729.7, summer 138.1747.6, autumn 121.4737.5,
r ¼ 0:624, P ¼ 0:000) values of FNNO. Day-to-day (morning values 14.676.7 vs.
14.275.1, r ¼ 0:784, P ¼ 0:000) week-to-week (morning values 14.676.7 vs.
15.477.3, r ¼ 0:738, P ¼ 0:000) and seasonal (autumn 14.677.2, winter
16.676.4, summer 17.478.0, r ¼ 0:709, P ¼ 0:000) levels of FENO were also highly
reproducible.
Serial FENO and FNNO measurements can be used in the monitoring of respiratory
tract inflammation. Due to the diurnal variation of FENO and FNNO, in long-term
follow-up the measurements should be performed at the same time of day.
& 2006 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserv
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(H. Stark).Introduction
The presence of NO in exhaled air of healthy
subjects was originally reported by Gustafssoned.
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H. Stark et al.266et al.1 Several publications have reported in-
creased levels of fractional exhaled NO (FENO) in
asthma and decline in these high levels after
corticosteroid treatment.2,3 For example, de-
creased levels of FENO have been detected in cystic
fibrosis and pulmonary hypertension.3 Little is
known about the effects of cold air and exercise
on NO production.4
The baseline levels of fractional nasal NO (FNNO)
are high compared to FENO, with the highest levels
being reported in paranasal sinuses.5–7 Both in-
creased and normal FNNO levels have been reported
in connection with allergic rhinitis.6,8 There are
decreases of FNNO in patients suffering from
sinusitis and the levels are low in individuals having
Kartagener syndrome.3,9
Direct measurements of FENO and FNNO are
performed by means of chemiluminescence analy-
sis. Both ATS and ERS have issued their recommen-
dations on how the measurements should be done,
and experimental data show that FENO values of
healthy individuals are between 10 and 20 ppb. The
FENO levels have been found to be inversely
correlated to exhalation flow rate and fixed flow
rate of 50mL s1 has been recommended.10–12
Recently, novel hand-held devices for FENO and
FNNO measurements have been developed and are
claimed to be appropriate for clinical studies.13,14
The levels of FNNO measured from different
laboratories vary from 30 to 2000 ppb because
there has not been a standardized technique for
measuring FNNO.
6 Silkoff et al.15 recommended the
use of a fixed flow exhalation technique for
measuring FNNO. In the recent ATS and ERS
recommendations there are detailed instructions
also for FNNO measurement.
12 In addition to the
previously reported techniques, new off-line meth-
ods for FNNO measurement have been developed.
7
In spite of the wide interest in nitric oxide there
are only a few reports about the reproducibility of
FENO and FNNO measurement techniques. The aim
of this study was to evaluate the short and long-
term variation of FNNO and FENO. In addition to
intraday, day-to-day and week-to-week variations
the seasonal variation was assessed. The study was
performed in eastern Finland where the outdoor
temperature varies considerably in the different
seasons.Methods
Subjects and measurement protocol
Twenty-one healthy, non-smoking, non-atopic sub-
jects (7 males and 14 females) volunteered toparticipate in the study. It was required that
smoking had been terminated at least half a year
before the study. The mean age of the subjects was
38.1 years (range 22–57 years). Those subjects who
had suffered upper or lower respiratory infections
in the 6 weeks prior to the study or who using any
medication were excluded. No intense exercise was
permitted during the 12 h before the measurements
and the subjects were not allowed to eat for 1 h
before the exhalations. The subjects were asked to
avoid nitrate-containing foods such as lettuce
during the study periods. Twenty-one subjects
participated in the study in the autumn, 18 in the
winter and 17 during the summer.
FENO and FNNO measurements were performed in
three periods: the first in autumn, the second in
winter and the third in summer. During the first
study day of autumn period the FENO and FNNO were
measured in the morning (at 7–9 O’clock) and again
6 h later in the afternoon (at 13–15 O’clock). In the
autumn period, both the morning and afternoon
measurements of the FENO and FNNO were repeated
24 h and 7 days after the first measurement day. In
winter and summer the FENO and FNNO measure-
ments were performed in the same day in the
morning (at 7–9 O’clock).
The study protocol was approved by the Ethics
Committee of the Kuopio University Hospital.Measurement Techniques of FENO and FNNO
FENO was measured by chemiluminescence analyser
(Sievers Model 280 NOA, Sievers Instruments INC.,
Boulder, CO, USA) according to ATS recommenda-
tions11 using the same protocol described earlier.16
According to the manufacture’s instructions the
instrument was not switched off and it was
calibrated each morning. During the study period
the instrument was also time-to-time calibrated in
the afternoon and no drift between the morning
and afternoon values was detected. The calibration
gas (AGA Gas Corp., Espoo, Finland) contained
carbon monoxide (13.7 ppm), carbon oxides
(o18 ppm) and nitrogen (15 ppm).
Briefly, when measuring FENO, the subjects
performed a slow vital capacity manoeuvre for
30 s against a fixed expiratory resistance. The
pressure level during exhalation was optimised by
following the computer screen on-line to reach a
constant 50mL s1 flow rate during the exhalation.
Exhaled air was led through a nonrebreathing valve
into a Teflon tubing system connected to the
analyser. The relative standard deviation between
three exhaled samples was to be o10% and the
detection limit for NO was 1 part per billion (ppb).
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laboratory under constant conditions. The chemi-
luminescence analyser was calibrated daily by using
zero air and a certified concentration of NO.
FNNO levels were measured by the application of
the fixed flow exhalation technique.15,17 Two soft,
well-fitting nose pieces were placed at the en-
trance of both nostrils. The pieces were attached
via a ‘‘Y’’ connector to a two-way valve and a
resistor was placed in the exhalation limb, which
required a pressure of 10 cm H2O to produce a flow
of 100mL/min. Subjects inhaled normal room
temperature air to total lung capacity (TLC) via
their mouths and exhaled nasally while targeting a
flow signal displayed on a computer monitor. The
expiration was continued until a steady NO plateau
lasting at least 10 s was reached. The contribution
of the oral NO was excluded. The measurement was
repeated three times and the mean value was
calculated.
Statistical methods
Means and standard deviations (SD) were used to
describe the NO data. Day-to-day and week-to-
week reproducibilities were visualised by using
Bland-Altman plots.18 Intraday, day-to-day, week-
to-week and seasonal variations of FENO and FNNO
and correlation between FENO and FNNO were
examined by intra-class correlation analysis (ICC).
ICC-values higher than 0.6 were considered to be
clinically significant.19 The coefficients of variation
were also calculated. In addition, intraday changes
of FENO and FNNO were studied by variance analysis
of repeated measures. The data were processed by
using the SPSS for Windows version 11.5 (SPSS
Inc.TM, Chicago, USA). A P-value o0.05 was
considered as being statistically significant.Results
In every measurement day, the morning levels of
FNNO were lower than those measured in the
afternoons. In the autumn, the afternoon values
of FNNO were significantly higher compared to
morning values in variance analysis (P ¼ 0:003)
and the correlation between morning and after-
noon levels was not clinically significant (r ¼ 0:565,
Table 1(A)).19 The day-to-day correlation of FNNO
levels was significant in the mornings but not in
the afternoons (r ¼ 0:868, r ¼ 0:543, respectively,
Table 1(B), Fig. 1(A)).
As in FNNO levels, the mean levels of FENO were
also regularly lower in the mornings compared to theafternoon values of the same day. There was a
significant difference between the morning and
afternoon values in the autumn in variance analysis
(Po0:001) even though there was also a clinically
significant correlation between the values
(r ¼ 0:830, Table 1(A)). Day-to-day correlation of
FENO was clinically significant when measured 24h
apart both in the mornings and the afternoons
(r ¼ 0:784, 0:779, respectively, Table 1(B), Fig. 1(B)).
The week-to-week correlation of FNNO was
clinically significant in both morning and afternoon
values (r ¼ 0:637, 0:781, respectively, Table 1(C),
Fig. 2(A)). With the 7 days interval, the correlation
between FENO measurements was also high in the
mornings (r ¼ 0:738, Table 1(C), Fig. 2(B)). When
comparing the afternoon week-to-week values of
the FENO measurements, no clinical significance
was reached (r ¼ 0:560, Table 1(C)).
Seasonal variations of both FENO and FNNO were
low, and the correlations were clinically significant
(r ¼ 0:709, 0:624, respectively, Table 1(D)).
FENO levels were clearly lower than the FNNO
levels and they did not correlate with each other at
any measurement point (r ¼ 0:191, Fig. 3).Discussion
The aim of this study was to assess short-term and
seasonal reproducibility of FENO and FNNO measure-
ments in healthy subjects. Due to the strict
exclusion criteria used it is anticipated that the
present FENO and FNNO data are not affected by
allergic or infection-related interferences.
It has been stated earlier that the reproducibility
of a single determination of FENO is high.
20,21 The
week-to-week reproducibility of FENO measure-
ment has also been reported to be high, and the
change of 30–35% or more in the FENO levels within
an interval of 1–3 weeks could be considered
abnormal.22 Our observations of both day-to-day
and week-to-week reproducibilities of FENO parallel
the previous findings. However, the week-to-
week correlation of FENO measured in the afternoon
did not entirely reach the clinically significant
level.
The morning levels of both FENO and FNNO were
consistently lower than those measured in the
afternoons of the same day. The difference was
more distinct in FNNO. In previous reports, the rise
in the NO levels over the day has been attributed to
dietary as well as metabolic factors.23,24 On the
other hand, the FENO levels did not rise to abnormal
levels in the afternoons when compared to refer-
ence values.10–12 The Sievers instrument used in
ARTICLE IN PRESS
Figure 1 Reproducibility of FNNO (A) and FENO (B) measurements collected in consecutive mornings 24 h apart
expressed by Bland–Altman plots. It is anticipated that 95% of the differences between measures will be o2 SD.
Table 1 Short-term and Seasonal Variations of FNNO and FENO studied by intra-class correlation analysis (ICC)
and coefficients of variation (CoV).
A. Intraday variation of FNNO and FENO (ppb) during three measurement days in autumn (mean7SD)
Mornings Afternoons n r P CoV (%)
FNNO 127.1728.9 149.2740.2 54 0.565 0.005 11.0
FENO 14.875.8 17.476.0 54 0.830 0.000 13.7
B. Day-to-day variation of FNNO and FENO (ppb) during the first week in autumn (mean7SD)
1st day 2nd day n r P CoV (%)
FNNO
Morning 121.4737.5 119.8729.6 21 0.868 0.000 8.1
Afternoon 136.0751.5 144.2745.0 21 0.543 0.004 17.5
FENO
Morning 14.676.7 14.275.1 21 0.784 0.000 16.1
Afternoon 16.777.2 16.875.6 21 0.779 0.000 14.7
C. Week-to-week variation of FNNO and FENO (ppb) during the autumn period (mean7SD)
1st week 2nd week n r P CoV (%)
FNNO
Morning 121.4737.5 128.0732.1 18 0.637 0.001 12.3
Afternoon 136.0751.5 151.4748.1 18 0.781 0.000 12.4
FENO
Morning 14.676.7 15.477.3 18 0.738 0.000 19.4
Afternoon 16.777.2 19.478.5 18 0.560 0.005 17.0
D. Seasonal variation of FNNO and FENO (ppb) in autumn, winter and summer mornings (mean7SD)
Autumn Winter Summer n r P CoV (%)
FNNO 121.4737.5 133.5729.7 138.1747.6 17 0.624 0.000 21.0
FENO 14.677.2 16.676.4 17.478.0 17 0.709 0.000 15.7
H. Stark et al.268this study was calibrated each morning and time to
time in the afternoon and no drift in the values was
found. Thus, the intraday changes in the nitric
oxide levels can be regarded as normal physiologi-
cal variation.In our previous report we assessed the effects of
Aspergillus fumigatus challenge on FENO and FNNO
levels and found that mould challenge caused a
rapid increase in FENO compared to placebo but no
differences in FNNO levels between mould and
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Figure 2 Reproducibility of FNNO (A) and FENO (B) measurements collected one week apart in the mornings expressed by
Bland–Altman plots. It is anticipated that 95% of the differences between measures will be o2 SD.
Figure 3 The correlation between FENO and FNNO levels (r ¼ 0:191, P ¼ 0:021, n ¼ 146) is very low mirroring their
different physiological functions.
Exhaled and nasal NO variation 269placebo challenges were found.17 However, in that
same study the FENO levels also slightly increased
during the day after placebo challenge and the
FNNO increased over the day after both A. fumiga-
tus and placebo exposures consistently with the
this study. In contrast with our results, Kharitonov
et al.13 did not found any diurnal variation in FENO
levels. However, the diurnal variation will need to
be taken into consideration when planning clinical
trials.
The present data suggests that seasonal changes
in air temperature do not impact on the phy-
siological NO production in the lower airways. This
is of special interest, since cold air has been
reported to associate with inflammatory cell
leakage into bronchial mucosa after exercise, but
changes in NO levels have not supported the
presence of active inflammation.4 It is worth noting
that in Finland the seasons differ from each otherin terms of outdoor temperature and humidity.
According to the Finnish Meteorological Institute
the mean outdoor temperatures (years 1900–2000)
in the area the study was performed were +9.0 1C in
autumn (September), 8.8 1C in winter (January)
and +16.5 1C in summer (June). In Finland, the
pollen season lasts from the beginning of May
until the end of August. Thus, significant changes
in NO levels during different seasons are pro-
bably related to allergy, asthma or respiratory
infections.
In line with a previous study, the day-to-day and
week-to-week variations of the FNNO levels were
low.25 However, day-to-day reproducibility of FNNO
measured in the afternoon was slightly below the
limit of clinical significance. Therefore, as in FENO
measurements, it is advisable to perform the serial
FNNO measurements in the morning to avoid these
confounding effects.
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ment was high in our healthy population. Since
elevated FNNO concentrations have been detected
in subjects with allergic rhinitis it could be
anticipated that the FNNO levels vary seasonally in
such patients. Surprisingly, Henriksen et al.26 did
not find elevation in FNNO levels during pollen
season in subjects with allergic rhinitis though
among the same population the FENO levels had
increased as expected. Interestingly, in a recent
case report acute purulent sinusitis was triggered
by topical nasal nitric oxide synthase inhibition.27
In this study, the FNNO levels in healthy subjects
were not affected by climatic factors such as cold
outdoor temperature or the presence of pollen in
the air.
In this study, FNNO levels were high compared to
FENO levels, which is in concordance with several
previous studies.6,28,29 This study showed that the
FNNO and FENO levels did not correlate with each
other. The FNNO and FENO concentrations reflect the
physiological status of the upper and lower airways,
and the role of NO in upper and lower airways is
known to be different.
The chemiluminescence technique for FENO mea-
surement used in this study is well-documented and
the mean levels of our measurements are in line
with previous studies.10–12 FNNO levels vary be-
tween laboratories with values from 30 to 2000 ppb
being reported. This has been explained as being
attributed to the different measurement techni-
ques6,14 but recently detailed instructions for FNNO
measurement have been given.12 According to an
earlier report, higher exhalation flow rates in FNNO
measurement (250 vs. 500mL/min) lead to higher
intraday and inter-day variability, and the FNNO
levels are inversely related to the flow rate.24 For
the FNNO measurements we used a low, steady flow
rate of 100mL/min and thus decreased the varia-
tion of FNNO levels and it may explain the high
reproducibility of current results.
Though the on-line method used in this study for
FENO and FNNO measurements is highly reproducible
and easy to perform for both the subject and the
researcher, the measurements require the presence
of several pieces of bulky, non-portable equipment.
This is a major limitation when planning larger
studies e.g. field studies in occupational settings. In
future, novel hand-held devices for FENO and FNNO
analyses will provide more flexible techniques and
portable devices for monitoring airway inflamma-
tion.
In conclusion, this report confirms that the short-
term and seasonal reproducibility of FENO and FNNO
levels is very good. Serial NO measurements are a
reliable tool in monitoring airway inflammation inboth upper and lower airways. However, the diurnal
variation needs to be taken into account, such that
in long-term follow-up the measurements should be
performed at the same time of the day, preferably
mornings rather than the afternoons. In addition,
climatic factors such as cold outdoor temperature
or pollen in the air do not affect the FNNO and FENO
levels in healthy subjects.Acknowledgements
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